Literature DB >> 17958438

Complexation of lipofectamine and cholesterol-modified DNA sequences studied by single-molecule fluorescence techniques.

Anca Margineanu1, Steven De Feyter, Sergey Melnikov, Damien Marchand, Arthur van Aerschot, Piet Herdewijn, Satoshi Habuchi, Frans C De Schryver, Johan Hofkens.   

Abstract

Lipoplex formation for normal and cholesterol-modified oligonucleotides is investigated by fluorescence correlation spectroscopy (FCS). To overcome the problems related to the fitting of autocorrelation curves when fluorescence bursts are present, the baseline fluorescence levels and the fluorescence bursts in the same trace were separately analyzed. This approach was not previously used in FCS studies of lipoplexes and allowed a more detailed characterization of this heterogeneous system. From the baseline levels, the number of free/bound DNA molecules and the presence of tens to hundreds of nanometer-sized lipoplexes were estimated using various mathematical models. Analysis of the fluorescent bursts provided an indication about the sizes of the lipoplexes, the number of DNA molecules in these aggregates, and the relative amount of lipids in each aggregate. An explanation for the higher transfection efficiency previously reported for one of the cholesterol-modified oligonucleotide compounds was found in relation to the formation of large size lipoplexes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17958438     DOI: 10.1021/bm700486q

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  2 in total

1.  Environmentally Triggerable Retinoic Acid-Inducible Gene I Agonists Using Synthetic Polymer Overhangs.

Authors:  Christian R Palmer; Max E Jacobson; Olga Fedorova; Anna M Pyle; John T Wilson
Journal:  Bioconjug Chem       Date:  2018-01-19       Impact factor: 4.774

2.  Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol.

Authors:  Abdelkader A Metwally; Ian S Blagbrough; Judith M Mantell
Journal:  Mol Pharm       Date:  2012-10-25       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.